Stories

Bob Herman Jan 25
SaveSave story

Big pharma's lobbying spree in Trump's first year

Groups representing drug companies heavily increased their federal lobbying in President Trump's first year, according to a review of lobbying records. No health care lobbying group splurged more than the Pharmaceutical Research and Manufacturers of America, which spent $25.4 million in 2017 — a 30% jump from 2016.

The big picture: The pharmaceutical industry went on red alert after Trump said drug companies were "getting away with murder" and had "a lot of power." It's worked: In the year since, Trump and Congress have not changed drug pricing laws.

Data: U.S. Senate Lobbying Disclosure Act Database; Chart: Chris Canipe / Axios